Excelsior Medical Co Ltd

Excelsior Medical Co Ltd maintains a relatively strong liquidity position, with a current ratio of 1.67, indicating that it has sufficient current assets to cover its current liabilities. However, the company's operating cash flow is negative at -1,363,630,000 TWD, which may raise concerns about its ability to sustain operations without external financing. The company's free cash flow is positive at 561,375,000 TWD, suggesting that it can fund operations and potentially invest in growth. In terms of profitability, Excelsior Medical Co Ltd reports a return on equity of 8.77% and a return on assets of 4.25%, which are key metrics for evaluating the company's efficiency in generating profits from its equity and assets. These figures should be compared to the industry median to determine if the company is outperforming or underperforming its peers. The company's gross profit of 1,874,371,000 TWD and operating income of 727,539,000 TWD further highlight its ability to generate earnings from its core operations. The company's revenue is concentrated in a single business segment, as no specific segments are disclosed in the available data. This lack of diversification may expose the company to higher risk if demand for its products or services declines in any particular area. Geographically, the company's exposure is not specified, but the absence of detailed geographic breakdowns suggests that it may not have significant international operations. Excelsior Medical Co Ltd's growth trajectory is not explicitly detailed in the available data, but the company's recent revenue of 8,789,236,000 TWD provides a baseline for assessing future performance. The company's capital expenditure of -83,038,000 TWD indicates that it is not currently investing heavily in new assets, which may suggest a focus on maintaining existing operations rather than expanding. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint. The company's debt-to-equity ratio of 0.23 suggests a relatively conservative capital structure, with a lower proportion of debt compared to equity. However, the negative operating cash flow may necessitate careful monitoring of its debt obligations and liquidity management. Recent events related to Excelsior Medical Co Ltd are not detailed in the available data. The company's financial performance and strategic direction would be better understood with access to recent filings, earnings calls, or other disclosures that provide insight into its operational and financial developments.